Abstract
Accurate estimates of gestational age at birth are important for preterm birth surveillance but can be challenging to reliably acquire in low and middle income countries. Our objective was to develop machine learning models to accurately estimate gestational age shortly after birth using clinical and metabolic data. We derived and internally validated three models using ELASTIC NET multivariable linear regression in heel prick blood samples and clinical data from a retrospective cohort of newborns from Ontario, Canada. We conducted external model validation in heel prick and cord blood sample data collected from prospective birth cohorts in Lusaka, Zambia (N=311) and Matlab, Bangladesh (N=1176). The best-performing model accurately estimated gestational age within about 6 days of early pregnancy ultrasound estimates in both cohorts when applied to heel prick data (MAE (95% CI) = 0.79 weeks (0.69, 0.90) for Zambia; 0.81 weeks (0.75, 0.86) for Bangladesh), and within about 7 days when applied to cord blood data (1.02 weeks (0.90, 1.15) for Zambia; 0.95 weeks (0.90, 0.99) for Bangladesh). Algorithms developed in Canada provided accurate estimates of gestational age when applied to external cohorts from Zambia and Bangladesh. Model performance was superior in heel prick data as compared to cord blood data.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This was not a clinical trial
Funding Statement
This study was supported by the Bill & Melinda Gates Foundation [OPP1141535] (OHRI), [OPP1033514] (UNC); with site support to Zambia provided by the US National Institutes of Health [P30 AI50410, D43 TW009340].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Zambia School of Medicine Biomedical Research Ethics Committee (016-04-14) University of North Carolina School of Medicine (14-2113) Research Review and Ethical REview Committees of the International Centre for Diarrhoeal Disease Research Bangladesh (PR-16039) Ottawa Health Science Network Research Ethics Board (20160219-01H) the Children's Hospital of Eastern Research Ethics Board (16/20E)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
shawken{at}ohri.ca, roducharme{at}ohri.ca, malmurphy{at}ohri.ca, bolibris{at}ohri.ca, bbota{at}ohri.ca, liwilson{at}ohri.ca, wei.cheng.stat{at}gmail.com, jlittle{at}uottawa.ca, Beth.Potter{at}uottawa.ca, kdenize{at}cheo.on.ca, MoLamoureux{at}cheo.on.ca, MHenderson{at}cheo.on.ca, Katelyn.Rittenhouse{at}unchealth.unc.edu, joni{at}email.unc.edu, Humphrey.mwape{at}unclusaka.org, vwalikab{at}gmail.com, pmuzho{at}hotmail.com, jpervin{at}icddrb.org, childcare1952{at}gmail.com, arahman{at}icddrb.org, PChakraborty{at}cheo.on.ca, jeffrey_stringer{at}med.unc.edu, kwilson{at}ohri.ca
Funding: This study was supported by the Bill & Melinda Gates Foundation [OPP1141535] (OHRI), [OPP1033514] (UNC); with site support to Zambia provided by the US National Institutes of Health [P30 AI50410, D43 TW009340].
Data Availability
A de-identified dataset can be provided upon reasonable, written request to the corresponding author and development of appropriate Data Sharing Agreements.
